147 related articles for article (PubMed ID: 19111794)
1. SUO/SBUR 2007 annual meeting proceedings: overview.
Evans CP
Urol Oncol; 2009; 27(1):33. PubMed ID: 19111794
[No Abstract] [Full Text] [Related]
2. Highlights of the 2008 SUO/SBUR annual meeting: current controversies in urologic oncology.
Kibel AS
Urol Oncol; 2009; 27(3):293-4. PubMed ID: 19414114
[No Abstract] [Full Text] [Related]
3. 2007 Annual Meeting of the Society of Urologic Oncology and the Society of Basic Urologic Research: Introduction.
Mohler JL
Urol Oncol; 2009; 27(1):34-5. PubMed ID: 19111795
[No Abstract] [Full Text] [Related]
4. [Urology].
Jichlinski P
Rev Med Suisse; 2014 Jan; 10(412-413):127-9. PubMed ID: 24558917
[TBL] [Abstract][Full Text] [Related]
5. Best approach for low-risk superficial bladder cancer.
Solsona E
ScientificWorldJournal; 2006 Oct; 6():2638-45. PubMed ID: 17619742
[TBL] [Abstract][Full Text] [Related]
6. Urological oncology in Europe. Research highlights from the XVIIth congress of the European Association of Urology, Birmingham, UK, February 23-26, 2002.
Thompson E
Drugs Today (Barc); 2002 Apr; 38(4):221-34. PubMed ID: 12532191
[No Abstract] [Full Text] [Related]
7. [Update urooncology: news with clinical relevance from major scientific meetings 2012].
Hegele A; Skrobek L; Schrader AJ
Aktuelle Urol; 2012 Dec; 43(6):376-87. PubMed ID: 23254351
[TBL] [Abstract][Full Text] [Related]
8. [Uro-oncological research from the laboratory and clinical practice].
Engeler D; Ludewig B; Schmid HP
Urologe A; 2008 Aug; 47(8):978-81. PubMed ID: 18521561
[TBL] [Abstract][Full Text] [Related]
9. [Bladder cancer update: what was new at the 2010 annual congress of the German Association of Urology in Düsseldorf?].
Nawroth R; Hartmann A; Olbert PJ; Merseburger AS; Stöhr R; Knüchel R; Retz M; Füssel S
Urologe A; 2011 Feb; 50(2):221-6. PubMed ID: 21246347
[TBL] [Abstract][Full Text] [Related]
10. New strategies in the treatment of Ta-T1 transitional cell carcinoma (TCC) of the bladder.
Brausi MA
ScientificWorldJournal; 2006 Oct; 6():2632-7. PubMed ID: 17619741
[TBL] [Abstract][Full Text] [Related]
11. The history and future of the Urologic Oncology Study Group (UOSG) of the Japan Clinical Oncology Group (JCOG).
Tobisu K
Jpn J Clin Oncol; 2012 May; 42(5):363-7. PubMed ID: 22450928
[TBL] [Abstract][Full Text] [Related]
12. Artificial Intelligence - Changing the Field of Prostate Cancer?
Rohan P; O'Reilly MK; Nason GJ
Ir Med J; 2020 Mar; 113(3):45. PubMed ID: 32815705
[No Abstract] [Full Text] [Related]
13. 6th Meeting of the European Society of Oncological Urology.
Govorov A
Expert Rev Anticancer Ther; 2009 Apr; 9(4):397-9. PubMed ID: 19374594
[TBL] [Abstract][Full Text] [Related]
14. Are we underutilizing minimally invasive approaches for upper tract urothelial carcinoma?
Wolf JS
Urol Oncol; 2009; 27(1):75-80. PubMed ID: 19111803
[TBL] [Abstract][Full Text] [Related]
15. The impact of variant histology on the outcome of bladder cancer treated with curative intent.
Black PC; Brown GA; Dinney CP
Urol Oncol; 2009; 27(1):3-7. PubMed ID: 18367107
[TBL] [Abstract][Full Text] [Related]
16. [Aspects of bladder cancer].
Jocham D; Stöckle M; Sommerauer M
Urologe A; 2012 Jun; 51(6):783. PubMed ID: 22674507
[No Abstract] [Full Text] [Related]
17. What's new in urology.
Williams RD
J Am Coll Surg; 2002 Nov; 195(5):663-74. PubMed ID: 12437254
[No Abstract] [Full Text] [Related]
18. Food and Drug Administration process for development and approval of drugs and radiopharmaceuticals: treatments in urologic oncology.
Ning YM; Maher VE
Urol Oncol; 2015 Mar; 33(3):137-42. PubMed ID: 25613202
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligences in urological practice: the key to success?
Cai T; Conti G; Lorenzini M; Bartoletti R
Ann Oncol; 2007 Mar; 18(3):604-5. PubMed ID: 17158777
[No Abstract] [Full Text] [Related]
20. In memoriam: a curious and careful gentleman--John P. Donohue, M.D.
Koch M; Nichols C
Urol Oncol; 2009; 27(1):1-2. PubMed ID: 19111793
[No Abstract] [Full Text] [Related]
[Next] [New Search]
